← Back to Dashboard

DIVISLAB Divi's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.45%
₹ 7,330.00
+0.16%
1-year price · range ₹5,698–₹7,248

Live setups screens DIVISLAB is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Covering
Price rose (+0.5%) on short-covering (OI down -1.1%), suggesting a temporary relief bounce rather than new buyers.

Analysis what the data is telling us about DIVISLAB

In the last completed session, Divi's Laboratories Ltd. closed +0.51% with futures open interest moving -1.1%. That combination — price rising while OI shrinks — is classified as Short Covering. It typically reflects existing short sellers closing positions, not fresh buying. Short-covering rallies can be sharp but tend to fade without follow-through demand. The option PCR of 1.08 is balanced — no clear directional preference from option writers. Max-pain strike at ₹7,100 sits 3.1% below the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Divi's Laboratories Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Divi's Laboratories Ltd. leans constructive into the next session. The next scheduled earnings report is on 2026-08-05, with the consensus EPS estimate at ₹24.67667. Earnings days routinely override positioning signals — keep an eye on the calendar.

F&O Positioning EOD derivatives setup

Buildup Class
Short Covering
bias: bullish
Futures OI
4,241,300
-47700 (-1.1%)
Option PCR (OI)
1.08
heavy put writing
Max Pain Strike
₹ 7,100
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 7,318.00
yesterday's EOD close
Index Contribution
+0.001 pp
contribution to Nifty
Traded Volume
179,558
live shares traded today
Upcoming Earnings
2026-08-05
EPS est: 24.67667

Technical Snapshot from 400 sessions of price history

RSI (14)
72.0
overbought
52-Week High
₹ 7,438.50
-1.6% from high
52-Week Low
₹ 5,636.50
+29.8% above low
200-DMA
₹ 6,438.22
+13.7% · above trend
50-DMA
₹ 6,780.25
+7.9% from 50-DMA
1-Year Return
+8.0%
1M +8.5%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
75.9
price / earnings
P/B
11.6
price / book
ROE
16.2%
return on equity
Market Cap
₹ 194,588 Cr
total market value
Dividend Yield
0.41%
trailing yield
EPS (TTM)
₹ 96.60
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-07-28 · spot 7,318 · EOD 2026-07-20

Option writers expect range between 6,650 and 7,500+2.5% upside, -9.1% downside.
downside-skewed
Call OI (writers) Strike Put OI (writers)
69,600 -8k
7000
208,500 +25k
26,000 -2k
7050
0
80,900 -7k
7100 MP
158,500 -14k
IV 27% Δ -0.20 θ -5.2 ν 3
20,600 -1k
7150
0
112,400 -17k
IV 16% Δ 0.79 θ -4.3 ν 3
7200
97,700 -16k
IV 27% Δ -0.31 θ -6.5 ν 4
51,500 -18k
IV 18% Δ 0.67 θ -5.5 ν 4
7250
0
202,500 -26k
IV 19% Δ 0.56 θ -6.1 ν 4
7300
180,300 -18k
IV 28% Δ -0.45 θ -7.4 ν 4
97,600 -27k
IV 20% Δ 0.46 θ -6.4 ν 4
7350
0
232,900 +108k
IV 21% Δ 0.37 θ -6.1 ν 4
7400
73,600 +52k
IV 31% Δ -0.58 θ -7.9 ν 4
269,700 +17k
IV 23% Δ 0.24 θ -5.4 ν 3
7500 R
13,400 +4k
IV 35% Δ -0.67 θ -8.3 ν 4
109,700 +11k
IV 25% Δ 0.15 θ -4.3 ν 2
7600
3,400 +0k
IV 35% Δ -0.77 θ -6.6 ν 3
57,200 +13k
7700
0
IV 249% Δ -0.49 θ -71.0 ν 4
52,100 +5k
7800
0
IV 255% Δ -0.50 θ -72.8 ν 4

Chain Interpretation

Spot Underlying 7,318.00
Key Resistance (R) 7,500
Key Support (S) 6,650
Max Pain Strike (MP) 7,100
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for DIVISLAB options · 2026-07-28 expiry

Underlying: DIVISLAB · Spot: ₹ 7,318.00 · Expiry: 2026-07-28 · Lot: 100

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

DIVISLAB — frequently asked questions

What is the Divi's Laboratories Ltd. share price today?

DIVISLAB is trading at ₹7,330.00 (+0.16% vs previous close), per the latest update on this page.

What is the P/E ratio of Divi's Laboratories Ltd.?

DIVISLAB (Divi's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 75.9.

What is the market cap of Divi's Laboratories Ltd.?

DIVISLAB has a market capitalisation of approximately ₹194,588 crore.

What is the ROE of Divi's Laboratories Ltd.?

DIVISLAB has a return on equity (ROE) of about 16.2%.

Is DIVISLAB near its 52-week high?

DIVISLAB is trading -1.6% from its 52-week high of ₹7,438.50 as of 2026-07-20.

What is the RSI of DIVISLAB?

The 14-day RSI of DIVISLAB is 72.0, which is considered overbought.

Is DIVISLAB above its 200-day moving average?

DIVISLAB is trading above its 200-DMA of ₹6,438.22 (+13.7% away).

What is the F&O buildup in DIVISLAB?

The latest end-of-day derivatives data classifies DIVISLAB as Short Covering (bias: bullish), based on the day's combined price and open-interest change.

What is the max pain and PCR for DIVISLAB options?

DIVISLAB's option-chain max pain strike is ₹7,100 and its put-call ratio (OI) is 1.08, from the latest end-of-day option chain.

Are FIIs or big investors buying DIVISLAB?

Strota tracks every bulk and block deal in DIVISLAB with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.